Slingshot Biosciences Announces Rapid Expansion into the United Kingdom and European Union Markets
Life sciences innovator and leader in precision-engineered synthetic cell mimic technology expands its UK/EU operations to accelerate cell and gene therapy and pharmaceutical development EMERYVILLE, Calif., Feb. 3, 2026 /PRNewswire/ — Slingshot
